Metro-Minnesota NCI Community Oncology Research Program — Saint Louis Park, Minnesota

Metro-Minnesota NCI Community Oncology Research Program is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Metro-Minnesota NCI Community Oncology Research Program has participated in 9 clinical trials.

Therapeutic areas: Recurrent Uterine Corpus Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro-Minnesota NCI Community Oncology Research Program?

Metro-Minnesota NCI Community Oncology Research Program has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro-Minnesota NCI Community Oncology Research Program conducted?

Metro-Minnesota NCI Community Oncology Research Program has 9 clinical trials on record. Their work covers Recurrent Uterine Corpus Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma.

Is Metro-Minnesota NCI Community Oncology Research Program accredited by Crixeo Health?

Yes — Metro-Minnesota NCI Community Oncology Research Program holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Metro-Minnesota NCI Community Oncology Research Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.